Ro-3306 is an ATP-competitive CDK1 inhibitor. It affects STAT3, Akt, and OTUB1/Cyclin E1 signaling pathways by binding to CDK1 and downregulating Cyclin B1/E1, effectively inhibiting cell proliferation and migration, while promoting apoptosis and G2/M cell cycle arrest.
Ro-3306 Mechanism of Action: CDK1 Inhibition in Cancer Cell Research
Ro-3306 MOA：Targeting CDK1/Apoptosis Pathway for Oncology Research